Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lantern Pharma Inc. (LTRN) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lantern Pharma Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1763950.
Total stock buying since 2020: $150,000.
Total stock sales since 2020: $7,097,750.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 254,087 | $792,304 | 0 | $0 |
| 2024 | 0 | $0 | 465,778 | $2,225,452 | 0 | $0 |
| 2023 | 0 | $0 | 290,696 | $999,994 | 0 | $0 |
| 2022 | 0 | $0 | 700,000 | $3,080,000 | 0 | $0 |
| 2020 | 10,000 | $150,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 141,613 | $455,470 | 0 | $0 |
| 2025-05 | 0 | $0 | 112,474 | $336,834 | 0 | $0 |
| 2024-05 | 0 | $0 | 60,000 | $378,200 | 0 | $0 |
| 2024-02 | 0 | $0 | 288,000 | $1,352,586 | 0 | $0 |
| 2024-01 | 0 | $0 | 117,778 | $494,666 | 0 | $0 |
| 2023-11 | 0 | $0 | 290,696 | $999,994 | 0 | $0 |
| 2022-11 | 0 | $0 | 700,000 | $3,080,000 | 0 | $0 |
| 2020-06 | 10,000 | $150,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | Bios Advisors Gp, Llc | Sale | 40,000 | 3.09 | 123,600 |
| 2025-06-13 | Bp Directors, Lp | Sale | 40,000 | 3.09 | 123,600 |
| 2025-06-12 | Bios Advisors Gp, Llc | Sale | 60,647 | 3.38 | 204,986 |
| 2025-06-11 | Bios Advisors Gp, Llc | Sale | 950 | 3.40 | 3,230 |
| 2025-06-10 | Bios Advisors Gp, Llc | Sale | 16 | 3.40 | 54 |
| 2025-05-29 | Bios Advisors Gp, Llc | Sale | 20,200 | 3.03 | 61,205 |
| 2025-05-29 | Bp Directors, Lp | Sale | 20,200 | 3.03 | 61,205 |
| 2025-05-28 | Bios Advisors Gp, Llc | Sale | 15,000 | 2.87 | 43,050 |
| 2025-05-28 | Bp Directors, Lp | Sale | 15,000 | 2.87 | 43,050 |
| 2025-05-27 | Bios Advisors Gp, Llc | Sale | 21,037 | 3.05 | 64,162 |
| 2025-05-27 | Bp Directors, Lp | Sale | 21,037 | 3.05 | 64,162 |
| 2024-05-24 | Bios Advisors Gp, Llc | Sale | 20,000 | 6.33 | 126,600 |
| 2024-05-24 | Bp Directors, Lp | Sale | 20,000 | 6.33 | 126,600 |
| 2024-05-23 | Bios Advisors Gp, Llc | Sale | 10,000 | 6.25 | 62,500 |
| 2024-05-23 | Bp Directors, Lp | Sale | 10,000 | 6.25 | 62,500 |
| 2024-02-29 | Bios Advisors Gp, Llc | Sale | 19,703 | 4.87 | 95,953 |
| 2024-02-29 | Bp Directors, Lp | Sale | 19,703 | 4.87 | 95,953 |
| 2024-02-28 | Bios Advisors Gp, Llc | Sale | 74,297 | 4.85 | 360,340 |
| 2024-02-28 | Bp Directors, Lp | Sale | 74,297 | 4.85 | 360,340 |
| 2024-02-27 | Bios Advisors Gp, Llc | Sale | 50,000 | 4.40 | 220,000 |
| 2024-02-27 | Bp Directors, Lp | Sale | 50,000 | 4.40 | 220,000 |
| 2024-01-17 | Bios Advisors Gp, Llc | Sale | 58,889 | 4.20 | 247,333 |
| 2024-01-17 | Bp Directors, Lp | Sale | 58,889 | 4.20 | 247,333 |
| 2023-11-29 | Bios Advisors Gp, Llc | Sale | 145,348 | 3.44 | 499,997 |
| 2023-11-29 | Bp Directors, Lp | Sale | 145,348 | 3.44 | 499,997 |
| 2022-11-08 | Bios Advisors Gp, Llc | Sale | 350,000 | 4.40 | 1,540,000 |
| 2022-11-08 | Bp Directors, Lp | Sale | 350,000 | 4.40 | 1,540,000 |
| 2020-06-11 | Keyser D Jeffrey | Buy | 10,000 | 15.00 | 150,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of LTRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lantern Pharma Inc. (symbol LTRN, CIK number 1763950) see the Securities and Exchange Commission (SEC) website.